Rocket Pharmaceuticals (RCKT) Assets (2014 - 2026)
Rocket Pharmaceuticals (RCKT) posted Assets of $423.1 million for Q2 2026, up 0.5% from $420.98 million a year earlier and up 48.2% from the prior quarter.
Rocket Pharmaceuticals (RCKT) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Rocket Pharmaceuticals' Assets came in at $330.45 million, down 37.4% from FY2024.
- Annual Assets shows a five-year compound annual growth rate of -11.0% (FY2020 to FY2025).
- In prior years, Rocket Pharmaceuticals' Assets was $527.7 million in FY2024 (-6.8%), $566.34 million in FY2023 (+2.6%), $551.81 million in FY2022 (+11.0%) and $497.02 million in FY2021 (-15.9%).
- The Q2 2026 figure stands as the highest quarterly Assets since Q1 2025.
- On a year-over-year basis, Assets increased in 1 of the last eight quarters, with an average decline of 16.9%.
- The strongest year-over-year quarter for Assets in the past five years was Q3 2021, with growth of 58.0%; the weakest was Q1 2026, with a decline of 39.4%.
- According to Business Quant data, Assets for the three prior quarters was $285.41 million (Q1 2026), $330.45 million (Q4 2025) and $368.03 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Rocket Pharmaceuticals | 283.71 Mn | 283.71 Mn | - | 423.10 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 423.10 Mn |
| Mar 31, 2026 | 285.41 Mn |
| Dec 31, 2025 | 330.45 Mn |
| Sep 30, 2025 | 368.03 Mn |
| Jun 30, 2025 | 420.98 Mn |
| Mar 31, 2025 | 471.07 Mn |
| Dec 31, 2024 | 527.70 Mn |
| Sep 30, 2024 | 393.69 Mn |
| Jun 30, 2024 | 446.41 Mn |
| Mar 31, 2024 | 499.44 Mn |
| Dec 31, 2023 | 566.34 Mn |
| Sep 30, 2023 | 598.76 Mn |
| Jun 30, 2023 | 461.78 Mn |
| Mar 31, 2023 | 514.76 Mn |
| Dec 31, 2022 | 551.81 Mn |
| Sep 30, 2022 | 417.27 Mn |
| Jun 30, 2022 | 431.85 Mn |
| Mar 31, 2022 | 460.15 Mn |
| Dec 31, 2021 | 497.02 Mn |
| Sep 30, 2021 | 530.24 Mn |
Rocket Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=RCKT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();